Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Atossa Therapeutics announced a plan to issue a stapled contingent value right (CVR) to shareholders tied to a potential rare pediatric disease Priority Review Voucher.
Shareholders would receive one CVR for each ATOS share held as of the record date or issued thereafterCVRs would entitle holders to 25% of net proceeds from monetization of Atossa's first qualifying priority review voucher, subject to a $50 million aggregate payment capSEATTLE, Sept. 29, 2026 /PRNe…